Insider Sell: Ginkgo Bioworks Holdings
5:23PM ET 1/27/2023 MT NewswiresJason R Kelly, Director, CEO and Founder, on January 26, 2023, sold 251,171 shares in Ginkgo Bioworks Holdings (DNA) for $443,480. Following the Form 4...
Quotes Snapshot > DNA
Ginkgo Bioworks Holdings Inc DNA:NYSE
Last Price$1.85Cboe Real-Time Last Sale as of 12:05PM ET 1/31/23
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.02(1.37%)
Bid (Size)$1.84 (33,850)
Ask (Size)$1.85 (27,212)
Day Low / High$1.79 - 1.91
Volume6.9 M
Read more news Recent News
Insider Sell: Ginkgo Bioworks Holdings
5:21PM ET 1/27/2023 MT NewswiresReshma P. Shetty, 10% Owner, Director, President, COO and Founder, on January 26, 2023, sold 339,992 shares in Ginkgo Bioworks Holdings (DNA) for $600,865....
Insider Sell: Ginkgo Bioworks Holdings
5:21PM ET 1/27/2023 MT NewswiresBarry Canton, 10% Owner, on January 26, 2023, sold 339,992 shares in Ginkgo Bioworks Holdings (DNA) for $600,865. Following the Form 4 filing with the SEC,...
Insider Sell: Ginkgo Bioworks Holdings
5:13PM ET 1/26/2023 MT NewswiresBarry Canton, 10% Owner, on January 24, 2023, sold 663,134 shares in Ginkgo Bioworks Holdings (DNA) for $1,174,058. Following the Form 4 filing with the...
View all Commentary and Analysis
Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update
12:27AM ET 1/30/2023 Seeking AlphaTracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update
1:28AM ET 1/27/2023 Seeking AlphaGinkgo Bioworks: Increasing Focus On Pharma And Biotech
11:42AM ET 1/12/2023 Seeking AlphaARKG: Despite A Huge Price Loss In 2022, Not The Right Time To Accumulate
1:22PM ET 1/04/2023 Seeking AlphaCompany Profile
Business Description
| Number of Employees | N/A |
| Recent SEC Filing | 01/27/2023 4 |
Company Highlights
| Price Open | $1.88 |
| Previous Close | $1.82 |
| 52 Week Range | $1.45 - 6.38 |
| Market Capitalization | $2.7 B |
| Shares Outstanding | 1.4 B |
| Sector | Health Services |
| Industry | Medical/Nursing Services | Next Earnings Announcement | 03/27/2023 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$2.27 |
| Beta vs. S&P 500 | N/A |
| Revenue | N/A |
| Net Profit Margin | -668.49% |
| Return on Equity | -233.08% |
Analyst Ratings as of 12/16/2022
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |